Publication | Closed Access
FDA'S policy statement for the development of new stereoisomeric drugs
569
Citations
0
References
1992
Year
Drug SafetyHealth PolicyBioequivalenceMedicinePharmacotherapyNew Stereoisomeric DrugsDrug DevelopmentPharmacologyDrug DiscoveryPre-clinical Pharmacology
No additional data available for this publication yet. Check back later!